Effect of Dietary Fiber Supplement on the Intestinal Microbiota Among Schizophrenia Patients
The Effect of Dietary Fiber Supplement on the Intestinal Microbiota Among Schizophrenia Patients With Central Obesity: a Pilot Study
1 other identifier
interventional
40
0 countries
N/A
Brief Summary
Background There has been much interest in the relationship between the types of gut microbiota and the development of obesity in recent years. It has been reported that the proportions of Firmicutes and Bacteroidetes differ between obese and normal weight human subjects. Human intestinal microbiota compositions have been found to be associated with long-term dietary habits and lifestyle. However, an increasing number of researches show that intestinal microbiota composition may be affected after short-term diet intervention. Importantly, obesity and metabolic problems play important roles in morbidity and mortality of schizophrenia patients. Human intestinal microbiota compositions related with obesity may impact the heath of this population. Therefore, we searched current advances about the connection of obesity, intestinal microbiota compositions, and diet in schizophrenia to conduct a clinical research focus on the effect of high fiber diet on the intestinal microbiota of schizophrenia patients with central obesity. Method We will investigate in a 4-week intervention whether consumption of dietary fiber supplement(Inulin) affect the microbiota composition in schizophrenia inpatients with central obesity. Fecal samples from participants before and after the intervention will be processed for the microbiota analysis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable schizophrenia
Started Jun 2018
Shorter than P25 for not_applicable schizophrenia
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 15, 2018
CompletedFirst Posted
Study publicly available on registry
June 11, 2018
CompletedStudy Start
First participant enrolled
June 20, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 20, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2018
CompletedJune 11, 2018
June 1, 2018
3 months
May 15, 2018
June 8, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Changes from baseline in microbiota composition at week 4
Fecal samples from participants before and after the intervention will be processed for microbiota analysis
4 weeks
Study Arms (1)
dietary fiber intervention group
EXPERIMENTALInterventions
We will investigate in a 4 week intervention whether consumption of dietary fiber supplement affect the microbiota composition in schizophrenia patients with central obesity.
Eligibility Criteria
You may qualify if:
- Schizophrenia inpatients
- Overweight and with central obesity
- agree to sign informed consent
You may not qualify if:
- Diagnosis of IBS
- Systemic antibiotic use during the past 4 weeks
- Excessive water intake
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of General Psychiatry Department
Study Record Dates
First Submitted
May 15, 2018
First Posted
June 11, 2018
Study Start
June 20, 2018
Primary Completion
September 20, 2018
Study Completion
December 30, 2018
Last Updated
June 11, 2018
Record last verified: 2018-06